A home-based care programme for rifampicin-resistant TB

Int J Tuberc Lung Dis. 2021 Jul 1;25(7):587-589. doi: 10.5588/ijtld.21.0051.

Authors

B Douglas-Jones¹, E Mohr-Holland², N Mema¹, S Mathee³, G Mathews⁴, S Hurribance⁴, V Scott⁴, A Reuter¹, J Furin⁵, C Pfaff¹

Affiliations

¹ Médecins Sans Frontières (MSF), Khayelitsha, Cape Town, South Africa.
² Médecins Sans Frontières (MSF), Khayelitsha, Cape Town, South Africa, MSF Southern Africa Medical Unit, Observatory, Cape Town, South Africa.
³ Provinical Government of the Western Cape Department of Health, Cape Town, South Africa.
⁴ City of Cape Town Health Department, Khayelitsha, Cape Town, South Africa.
⁵ Harvard Medical School, Boston, MA, USA.

PMID: 34183106
DOI: 10.5588/ijtld.21.0051

No abstract available

Publication types

Letter

MeSH terms

Antibiotics, Antitubercular* / therapeutic use
Antitubercular Agents / therapeutic use
Home Care Services*
Humans
Mycobacterium tuberculosis*
Rifampin
Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

Antibiotics, Antitubercular
Antitubercular Agents
Rifampin